Journal article icon

Journal article

Vedolizumab in paediatric Inflammatory Bowel Disease: A retrospective multi-centre experience From the paediatric IBD Porto Group of ESPGHAN

Abstract:

Background

Vedolizumab, an anti-integrin antibody, has proven to be effective in adults with Inflammatory Bowel Disease (IBD), but the data in pediatrics are limited. We describe the short-term effectiveness and safety of vedolizumab in a European multi-center pediatric IBD cohort.

Method

Retrospective review of children (2-18 years) treated with vedolizumab from 19 centers affiliated with the Paediatric IBD Porto group of ESPGHAN. Primary outcome was week 14 cort...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.1093/ecco-jcc/jjx082

Authors


Escher, JC More by this author
De Ridder, L More by this author
Expand authors...
Publisher:
Oxford University Press Publisher's website
Journal:
Journal of Crohn's and Colitis Journal website
Volume:
11
Issue:
10
Pages:
1230-1237
Publication date:
2017-06-09
DOI:
EISSN:
1876-4479
ISSN:
1873-9946
Pubs id:
pubs:738576
URN:
uri:58086eb5-7697-4b7d-98e3-1d902b4b8e0e
UUID:
uuid:58086eb5-7697-4b7d-98e3-1d902b4b8e0e
Local pid:
pubs:738576

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP